BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30002362)

  • 21. Analysis of Data from the Oxygen Persufflation in Liver Transplantation (OPAL) Study to Determine the Role of Factors Affecting the Hepatic Microcirculation and Early Allograft Dysfunction.
    Benkö T; Belker J; Gallinat A; Treckmann JW; Paul A; Minor T; Hoyer DP
    Ann Transplant; 2019 Aug; 24():481-488. PubMed ID: 31417074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Allograft Dysfunction Increases Hospital Associated Costs After Liver Transplantation-A Propensity Score-Matched Analysis.
    Moosburner S; Sauer IM; Förster F; Winklmann T; Gassner JMGV; Ritschl PV; Öllinger R; Pratschke J; Raschzok N
    Hepatol Commun; 2021 Mar; 5(3):526-537. PubMed ID: 33681684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive Role of Intraoperative Serum Brain Natriuretic Peptide for Early Allograft Dysfunction in Living Donor Liver Transplantation.
    Chae MS; Koo JM; Park CS
    Ann Transplant; 2016 Aug; 21():538-49. PubMed ID: 27572618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity-Matched Cohort.
    Croome KP; Lee DD; Croome S; Nakhleh RE; Abader Sedki Senada P; Livingston D; Yataco M; Taner CB
    Liver Transpl; 2019 Oct; 25(10):1533-1540. PubMed ID: 31187923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the Predictive Ability for Graft Loss and Mortality of Two Criteria for Early Allograft Dysfunction After Liver Transplantation.
    Brea-Gómez E; Villar-Quintana R; Plata-Illescas C; Zambudio-Carroll N; Lopez-Garrido MA; Nogueras-Lopez F; Muffak-Granero K; Becerra-Massare A; Villegas-Herrera MT; Segura Jiménez I; Muñoz Pérez N; Villar-Del-Moral JM
    Transplant Proc; 2018 Mar; 50(2):605-609. PubMed ID: 29579865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Graft Regeneration and Functional Recovery in Patients with Early Allograft Dysfunction After Living-Donor Liver Transplantation.
    Chae MS; Kim Y; Lee N; Chung HS; Park CS; Lee J; Choi JH; Hong S
    Ann Transplant; 2018 Jul; 23():481-490. PubMed ID: 30013021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early post-operative acute phase response in patients with early graft dysfunction is predictive of 6-month and 12-month mortality in liver transplant recipients.
    Oweira H; Lahdou I; Daniel V; Opelz G; Schmidt J; Zidan A; Mehrabi A; Sadeghi M
    Hum Immunol; 2016 Oct; 77(10):952-960. PubMed ID: 27476050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective, single-centre, randomised controlled trial to evaluate the efficacy and safety of ischaemia-free liver transplantation (IFLT) in the treatment of end-stage liver disease.
    Huang C; Huang S; Tang Y; Zhao Q; Wang D; Ju W; Yang L; Zhang J; Wu L; Chen M; Zhang Z; Zhu Z; Wang L; Zhu C; Zhang Y; Sun C; Xiong W; Shen Y; Chen X; Ma Y; Hu A; Zhu X; Rong J; Cai C; Guo Z; He X
    BMJ Open; 2020 May; 10(5):e035374. PubMed ID: 32376754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction model for early graft failure after liver transplantation using aspartate aminotransferase, total bilirubin and coagulation factor.
    Rhu J; Kim JM; Kim K; Yoo H; Choi GS; Joh JW
    Sci Rep; 2021 Jun; 11(1):12909. PubMed ID: 34145352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. von Willebrand factor to protein C ratio-related thrombogenicity with systemic inflammation is predictive of graft dysfunction after liver transplantation: Retrospective cohort study.
    Kwon HM; Kim KS; Park J; Jeong J; Moon YJ; Song JG; Hwang GS; Kim KH; Jun IG
    Int J Surg; 2020 Dec; 84():109-116. PubMed ID: 33137460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antegrade Arterial and Portal Flushing Versus Portal Flushing Only for Right Lobe Live Donor Liver Transplantation-A Randomized Control Trial.
    Pamecha V; Sandhyav R; Sinha PK; Bharathy KGS; Sasturkar S
    Transplantation; 2018 Apr; 102(4):e155-e162. PubMed ID: 29334530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the updated definition of early allograft dysfunction in donation after brain death and donation after cardiac death liver allografts.
    Croome KP; Wall W; Quan D; Vangala S; McAlister V; Marotta P; Hernandez-Alejandro R
    Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):372-6. PubMed ID: 22893463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of High-Mobility Group Box 1 (HMGB1) Expression as a Potential Predictor of Rejection and Poor Prognosis After Liver Transplantation.
    Ye Z; Jia J; Lv Z; Zheng S
    Ann Transplant; 2021 Jul; 26():e931625. PubMed ID: 34282108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of DCD liver transplantation using organs treated by hypothermic oxygenated perfusion before implantation.
    Schlegel A; Muller X; Kalisvaart M; Muellhaupt B; Perera MTPR; Isaac JR; Clavien PA; Muiesan P; Dutkowski P
    J Hepatol; 2019 Jan; 70(1):50-57. PubMed ID: 30342115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interstitial Glucose Metabolism Monitoring as an Additional Method for Objective Assessment of Donor Liver, Prediction and Immediate Diagnosis of Early Graft Dysfunction.
    Sushkov AI; Voskanyan SE; Rudakov VS; Popov MV; Gubarev KK; Svetlakova DS; Artemiev AI
    Sovrem Tekhnologii Med; 2022; 14(3):28-39. PubMed ID: 37064804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Model for Early Allograft Function" Outperforms "Early Allograft Dysfunction" as a Predictor of Transplant Survival.
    Jochmans I; Fieuws S; Monbaliu D; Pirenne J
    Transplantation; 2017 Aug; 101(8):e258-e264. PubMed ID: 28557956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of intelligent/interactive qualitative and quantitative analysis-three-dimensional estimated model in donor-recipient size mismatch following deceased donor liver transplantation.
    Ding H; Ding ZG; Xiao WJ; Mao XN; Wang Q; Zhang YC; Cai H; Gong W
    World J Gastroenterol; 2023 Nov; 29(44):5894-5906. PubMed ID: 38111507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The histological assessment of liver fibrosis in grafts from extended criteria donors predicts the outcome after liver transplantation: A retrospective study.
    D'Errico A; Riefolo M; Serenari M; De Pace V; Santandrea G; Monica M; de Cillia C; Ravaioli M; Cescon M; Vasuri F;
    Dig Liver Dis; 2020 Feb; 52(2):185-189. PubMed ID: 31155489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a Novel Prognostic Nomogram for High Model for End-Stage Liver Disease Score Recipients Following Deceased Donor Liver Transplantation.
    Yang M; Khan AR; Lu D; Wei X; Shu W; Xu C; Pan B; Zhou Z; Wang R; Wei Q; Cen B; Cai J; Zheng S; Xu X
    Front Med (Lausanne); 2022; 9():772048. PubMed ID: 35308496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early allograft dysfunction in liver transplantation with donation after cardiac death donors results in inferior survival.
    Lee DD; Singh A; Burns JM; Perry DK; Nguyen JH; Taner CB
    Liver Transpl; 2014 Dec; 20(12):1447-53. PubMed ID: 25179581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.